SARS-CoV-2 Rapid Antigen Testing of Symptomatic and Asymptomatic Individuals on the University of Arizona Campus

Department of Immunobiology & Medicine, College of Medicine-Tucson, University of Arizona Health Sciences, University of Arizona, Tucson, AZ 85724, USA

College of Medicine-Tucson, University of Arizona Genetics Core, University of Arizona, Tucson, AZ 85724, USA

⁴

Department of Athletic, University of Arizona, Tucson, AZ 85724, USA

⁵

Data Science Institute, University of Arizona, Tucson, AZ 85724, USA

⁶

Department of Surgery, College of Medicine-Tucson, University of Arizona, Tucson, AZ 85724, USA

⁷

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, College of Medicine-Tucson, University of Arizona, Tucson, AZ 85724, USA

⁸

Department of Medicine, University of Arizona-Phoenix, Phoenix, AZ 85724, USA

⁹

Department of Emergency Medicine, College of Medicine-Tucson, Tucson, AZ 85724, USA

¹⁰

Department of Pathology, University of Arizona College of Medicine-Tucson, University of Arizona, Tucson, AZ 85724, USA

¹¹

Office of the Senior Vice-President for Health Sciences, University of Arizona, Tucson, AZ 85724, USA

Author to whom correspondence should be addressed.

Academic Editor: David G. Alleva

Biomedicines 2021, 9(5), 539; https://doi.org/10.3390/biomedicines9050539

Received: 12 April 2021 / Revised: 29 April 2021 / Accepted: 5 May 2021 / Published: 12 May 2021

(This article belongs to the Section Molecular and Translational Medicine)

View Full-Text Download PDF

Browse Figure

Review Reports Citation Export

Abstract

SARS-CoV-2, the cause of COVID19, has caused a pandemic that has infected more than 80 M and killed more than 1.6 M persons worldwide. In the US as of December 2020, it has infected more than 32 M people while causing more than 570,000 deaths. As the pandemic persists, there has been a public demand to reopen schools and university campuses. To consider these demands, it is necessary to rapidly identify those individuals infected with the virus and isolate them so that disease transmission can be stopped. In the present study, we examined the sensitivity of the Quidel Rapid Antigen test for use in screening both symptomatic and asymptomatic individuals at the University of Arizona from June to August 2020. A total of 885 symptomatic and 1551 asymptomatic subjects were assessed by antigen testing and real-time PCR testing. The sensitivity of the test for both symptomatic and asymptomatic persons was between 82 and 90%, with some caveats. View Full-Text

Keywords: rapid antigen test; PCR; SARS-CoV-2; asymptomatic; diagnostic screening

▼ Show Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Share and Cite

MDPI and ACS Style

Harris, D.T.; Badowski, M.; Jernigan, B.; Sprissler, R.; Edwards, T.; Cohen, R.; Paul, S.; Merchant, N.; Weinkauf, C.C.; Bime, C.; Erickson, H.E.; Bixby, B.; Parthasarathy, S.; Chaudhary, S.; Natt, B.; Cristan, E.; El Aini, T.; Rischard, F.; Campion, J.; Chopra, M.; Insel, M.; Sam, A.; Knepler, J.L.; Knox, K.; Mosier, J.; Spier, C.; Dake, M.D. SARS-CoV-2 Rapid Antigen Testing of Symptomatic and Asymptomatic Individuals on the University of Arizona Campus. Biomedicines 2021, 9, 539. https://doi.org/10.3390/biomedicines9050539

AMA Style

Harris DT, Badowski M, Jernigan B, Sprissler R, Edwards T, Cohen R, Paul S, Merchant N, Weinkauf CC, Bime C, Erickson HE, Bixby B, Parthasarathy S, Chaudhary S, Natt B, Cristan E, El Aini T, Rischard F, Campion J, Chopra M, Insel M, Sam A, Knepler JL, Knox K, Mosier J, Spier C, Dake MD. SARS-CoV-2 Rapid Antigen Testing of Symptomatic and Asymptomatic Individuals on the University of Arizona Campus. Biomedicines. 2021; 9(5):539. https://doi.org/10.3390/biomedicines9050539

Chicago/Turabian Style

Harris, David T., Michael Badowski, Brandon Jernigan, Ryan Sprissler, Taylor Edwards, Randall Cohen, Stephen Paul, Nirav Merchant, Craig C. Weinkauf, Christian Bime, Heidi E. Erickson, Billie Bixby, Sairam Parthasarathy, Sachin Chaudhary, Bhupinder Natt, Elaine Cristan, Tammer El Aini, Franz Rischard, Janet Campion, Madhav Chopra, Michael Insel, Afshin Sam, James L. Knepler, Kenneth Knox, Jarrod Mosier, Catherine Spier, and Michael D. Dake 2021. "SARS-CoV-2 Rapid Antigen Testing of Symptomatic and Asymptomatic Individuals on the University of Arizona Campus" Biomedicines 9, no. 5: 539. https://doi.org/10.3390/biomedicines9050539

Find Other Styles

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Abstract views Pdf views Html views

Article Menu

SARS-CoV-2 Rapid Antigen Testing of Symptomatic and Asymptomatic Individuals on the University of Arizona Campus

Abstract

Share and Cite

Article Metrics

Article Access Statistics

Article Access Map by Country/Region

Further Information

Guidelines

MDPI Initiatives

Follow MDPI